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Background: Both medical disputes and the incidence of skin 
cancer are increasing in Korea. Objective: The aim of this 
study was to figure out the medical litigation related to skin 
cancer and propose a method to prevent the medical dis-
putes. Methods: Skin cancer-related judgments were search-
ed by The Supreme Court of Korea’s Written Judgment 
Management System based on the keywords for skin cancer. 
The search system included sentenced cases at the Lower 
Courts, the Appellate Courts, and the Supreme Court from 
1997 to 2017. Results: Seven cases were selected as the liti-
gation cases related to skin cancer. Four cases (57.1%) pre-
sented malignant melanoma, while the rest presented squ-
amous cell carcinoma, metastatic skin cancer, and periph-
eral T cell lymphoma (1 case in each). Four cases resulted in 
death from cancer metastasis, and 3 cases presented as 
sequelae. The legal issues related to the medical disputes 
could be categorized as follows: misdiagnosis, delayed diag-
nosis, performance error, and lack of informed consent. 
Delayed diagnosis and lack of informed consent were the 
most common issues (n=4) in the precedents. Five cases 
(71.4%) were sentenced the awarded amounts to the plain-
tiff, including 2 cases of settlement decision. The average 
awarded amount was 42,553,644±27,567,455 Korean won. 
Conclusion: Physicians should pay attention to the cases of 
the skin cancer to prevent medical malpractice and disputes. 
The practices pertaining to proper diagnosis, treatment plans, 
and obtaining an informed consent should be followed dur-
ing the course of treating skin cancer. (Ann Dermatol 31(3) 
300∼306, 2019)
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INTRODUCTION
Medical disputes are increasing worldwide. Recently, re-
searches about medical disputes are presenting the view-
points of the cause of the medical malpractice or the dis-
pute, while deviating from the existing concept that eval-
uates the liability of doctors and patients with regards to 
medical accidents1,2. In recent years, studies on medical 
malpractice and conflict prevention by medical litigation 
analysis in Republic of Korea have been published3-6. In 
dermatology, no paper dealing with specific medical dis-
putes has been reported thus far.
Skin cancer is increasing due to the exposure of ultraviolet 
radiation by ozone depletion, longer life expectancy, in-
creased early detection rates, and rising public awareness 
by education7. The prevalence of the skin cancer in Korea 
is relatively low in comparison to the western countries. 
However, recent epidemiological studies have reported 
that the incidence of the skin cancer is steadily increas-
ing7-10. 
Legal issues related to the skin cancers have been rela-
tively low in Korea. However, the prevalence of the skin 
cancers is increasing, and the legal access to medical liti-
Judicial Precedents Regarding Skin Cancer in Korea
Vol. 31, No. 3, 2019 301
gation is rising due to changes in the legal environment, 
hence medico-legal considerations related to the skin can-
cer are likely to increase in the near future. Therefore, in 
this study, the authors investigated the litigated cases re-
lated to the malignant skin tumors in the past, and then 
proposed a method to prevent and manage the medical 
disputes based on the cases discussed to seek the judg-
ment. 
MATERIALS AND METHODS
This research included skin cancer-related civil proceed-
ings sentenced within the courts of Korea from 1997 to 
2017.
The researchers selected the precedents pertaining to the 
compensatory damage from medical malpractice and in 
which the disputed disease was skin cancer. To collect the 
case-related decisions, the researchers visited the Special 
Collections Reading Room with the permission of the Su-
preme Court Library of Korea. The Supreme Court of Korea’s 
Written Judgment Management System, a searching en-
gine for written judgments, is available at the Special Col-
lections Reading Room. Some skin cancer-related search 
terms were set to avoid missing any case-related judg-
ments. Considering the common histologic types of the 
skin cancer, following search terms were included: “skin 
cancer”, “malignant melanoma (MM)”, “basal cell carcino-
ma (BCC)”, “squamous cell carcinoma (SCC)”, “skin meta-
stasis”, “(extramammary) Paget’s disease”, “mycosis fun-
goides”, “cutaneous lymphoma”, “leukemia cutis”, “Bowen’s 
disease”, “angiosarcoma”, “Kaposi’s sarcoma”, and “der-
matofibrosarcoma protuberans”.
After searching the related precedents, the researchers re-
quested to review the official copies of the written judg-
ment available with the Lower Courts, the Appellate Courts, 
and the Supreme Court. The analyzed contents in each li-
tigated case included basic information of the plaintiffs 
and the defendants, clinical characteristics, and legal issues.
The issues of primary disputes were categorized as fol-
lows11: Misdiagnosis was defined in the cases presenting 
failure to suspect the skin cancer at the initial diagnosis; 
delayed diagnosis was stipulated in the cases that consid-
ered the skin cancer as the initial diagnosis, but failed to 
make the final diagnosis appropriately; performance error 
was inferred from the cases with improper management 
even after proper diagnosis.
The detailed analysis of each precedent was performed in-
dependently by a dermatologist (Cho SI) for the dermato-
logical issues and by a researching physician (Shin SH) for 
the medical law and ethics. In cases of disagreement be-
tween the two authors, the clinical issues were decided af-
ter discussing with the other dermatologist (Mun JH), and 
the legal issues were decided after discussing with the 
doctor of public health (Lee W).
RESULTS
Keywords and search results
After searching, a total of 132 official copies of written 
judgments were received from each court. The researchers 
collected the precedents for each search term following 
the process of deletion of personally identifiable infor-
mation by the courts (“skin cancer” [10 cases], “MM” [14 
cases], “BCC” [0 case], “SCC” [11 cases], “skin metastasis 
or metastatic skin cancer” [5 cases], “[extramammary] 
Paget’s disease” [2 cases], “mycosis fungoides” [0 case], 
“cutaneous lymphoma” [8 cases], “leukemia cutis” [78 
cases], “Bowen’s disease” [0 case], “angiosarcoma” [4 cas-
es], “Kaposi’s sarcoma” [0 case], and “dermatofibrosarco-
ma protuberans” [0 case]). Of the collected case-related 
judgments, several judgments were excluded, namely, over-
lapped judgments, rulings mentioned by the search term 
that were not the issues of litigation, precedents related to 
the employment injuries, and cases of the carcinomas oth-
er than the skin including the mucous membrane. Finally, 
7 unique cases were selected that were identified as per-
taining to medical malpractice lawsuits regarding skin can-
cer (Fig. 1). 
Analysis of the judicial precedents involving the skin 
cancer
Of the total 7 litigated cases, 4 cases were disputed for the 
MM. SCC, metastatic skin cancer, and peripheral T-cell 
lymphoma were reported in 1 case each. Disability and 
complication including death from cancer metastasis were 
reported in 4 cases, limb amputation in 1 case, mastica-
tion and pronunciation disorder in 1 case, and hypo-
gonadism with azoospermia was reported in 1 case (Fig. 
2). Of the total 7 cases, 3 cases (42.9%) were judged in fa-
vor of the plaintiff. In 2 cases, the court dismissed the 
plaintiffs’ claims, and the other 2 cases involved the settle-
ment decision. Table 1 shows a detailed clinical summary 
of each case.
The types of medical institutions included 6 university 
hospitals and 1 local clinic. All the defendants were legal 
entities. With regard to the medical specialties that led to 
the lawsuit, there were mainly the departments perform-
ing the medical examination, such as dermatology, dental 
medicine, rheumatology, general surgery, plastic surgery, 
and radiation oncology with an exception of the depart-
ment of pathology dealing with the pathologic specimens.
Of the 7 sentenced cases, 4 cases (57.1%) were resolved 
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Fig. 1. A total of 7 cases of the 
judicial precedents were analyzed 
in this study. The skin cancer re-
lated search terms included “skin
cancer”, “malignant melanoma”,
“basal cell carcinoma”, “squamous
cell carcinoma”, “skin metastasis”,
“(extramammary) Paget’s disease”,
“mycosis fungoides”, “cutaneous
lymphoma”, “leukemia cutis”, “Bo-
wen’s disease”, “angiosarcoma”,
“Kaposi’s sarcoma”, and “dermato-
fibrosarcoma protuberans”.
Fig. 2. Diagnosis and complications
of the skin cancer in all the 7 cases 
of the judicial precedents.
Table 1. Clinical summary of the cases pertaining to the judicial precedents regarding the skin cancer
Case
Year 
(clinical event)
Sex/age 
(yr)
Initial diagnosis Final diagnosis
Anatomical 
location
Disputed
main issue
Damage/complication 
(year)
#1 2007 F/NI Radiation recall dermatitis 
or contact dermatitis
Skin metastasis 
from breast cancer
Chest Misdiagnosis Death from metastasis (2009)
#2 2008 M/NI Bacterial skin infection Squamous cell 
carcinoma
Lower leg Delayed 
diagnosis
Limb amputation (2009)
#3 2007 F/55 Melanocytic nevus MM Left lateral 
ankle
Delayed 
diagnosis
Death from metastasis (2010)
#4 2009 M/NI Oral melanocytic nevus MM Gingiva Misdiagnosis Death from metastasis (2014)
#5 2009 M/32 Epithelioid hemangioma MM Gingiva Delayed 
diagnosis
Language disability 
(mastication&pronunciation)
#6 2005 M/41 MM MM Forehead Performance 
error
Death from metastasis (2007)
#7 2005 M/NI Cellulitis→panniculitis Peripheral T cell 
lymphoma
Leg Delayed 
diagnosis
Hypogonadism with 
azoospermia
F: female, M: male, NI: not identifiable, MM: malignant melanoma.
at the first instance; whereas 2 cases proceeded to the 
Appellate Court and 1 case to the Supreme Court. The 
average awarded amount was 42,553,644±27,567,455 
Korean won (KRW, mean±standard deviation; range, 
15,000,000∼74,277,111 KRW); and the average amount 
claimed was 180,486,445±59,640,477 KRW (range, 
129,384,456∼274,252,613 KRW) (Table 2).
DISCUSSION
This study analyzed a total of 7 medical malpractice law-
suits with regard to the skin cancer registered in the past 
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Table 2. Summary of the judgments in the cases of the judicial precedents regarding the skin cancer (unit: Korean won)
Case
Year (clinical visit/
start lawsuit/
final sentence)
Claimed 
amounts 
Trial 
outcome
Awarded 
amounts
Details of awarded amounts*
Lost earning 
capacity 
(disability rate, %)
Cost of treatment, 
convalescent
care, etc.
Limitation 
of liability 
(%)
Consolation 
money
#1 2007/2010/2011 
(appellate court)
129,384,456 Partially award-
ed to plaintiff
15,000,000 0 0 15,000,000
#2 2008/2010/2011 141,742,662 Settlement 
decision
70,000,000
#3 2007/2011/2012 158,754,989 Partially award-
ed to plaintiff
23,491,109 49,455,557
(100)
3,000,000 20 13,000,000
#4 2009/2015/2015 256,022,578 Dismissal 0
#5 2009/2013/2017 
(appellate court)
168,847,080 Partially award-
ed to plaintiff
74,277,111 254,365,837 
(30)
17,019,772 20 20,000,000
#6 2005/2006/2008 274,252,613 Settlement 
decision
30,000,000
#7 2005/2008/2013 
(supreme court)
134,400,736 Dismissal 0
*Awarded amounts were calculated as followed: (lost earning capacity+cost of treatment, convalescent care, etc.)×limitation of liability
+consolation money.
Table 3. Plaintiff’s allegation and the medical disputes listed in
each case-related judgment 
Case
Misdi-
agnosis
Delayed diagnosis
Perfor-
mance 
error
Lack of 
informed 
consent
Not/delayed 
check the 
pathology report
Pathology 
interpretation 
error
#1 ○
#2 D
#3 ○
#4 × ×
#5 ○* × ×
#6 D D
#7 × ×
○: in favor of the plaintiff, D: settlement decision, ×: dismissal
for claim. *CD31 was mis-interpreted as positive in the primary
histologic examination.
20 years (1997∼2017) in Korea. Except for 2 cases, the 
other 5 judicial cases were filed since 2010. Increasing 
pattern of the malpractice claims since 2010 was also re-
ported in another study related to the plastic surgery3. The 
course of the skin cancer involves a long time from the di-
agnosis to the fatal outcome. This study revealed that, for 
a skin cancer to attain the final outcome, several years 
elapsed ranging from at least 2 years to the maximum 5 
years. Literature reports in Korea have reported a steady 
increase in the skin cancer incidence in Korea7-9. Con-
sidering this, the skin cancer related lawsuits are likely to 
increase in the near future.
Every doctor, including a dentist, needs to know about the 
skin findings suspected of malignancy, and should keep in 
mind the possibility of developing skin cancer. Skin can-
cers, such as MM and SCC, are common in skin areas ex-
posed to ultraviolet rays, but may also occur in the oral 
cavity or gum12,13. Metastatic skin cancer can manifest at 
various sites of the body according to the type of the can-
cer of primary origin14. Cutaneous lymphoma may involve 
multiple systemic symptoms with skin involvement at vari-
ous sites15. In this study, a majority of cases were related 
to the MM. In a study of analysis of 99 litigation cases re-
lated to the skin cancer, BCC (n=25), MM (n=24), and 
SCC (n=20) were the most common16. 
The medical disputes regarding the skin cancer can occur 
at various stages of the treatment course17. It can be div-
ided into 3 main steps: 1) when a patient meets a physi-
cian in the examination room, and a differential diagnosis 
is made (misdiagnosis), 2) when the final diagnosis is con-
firmed by the clinicians or pathologists (delayed diag-
nosis), 3) when a clinician decides the method of treat-
ment, and treats the patient based on the final diagnosis 
(performance error). These steps involve the physicians of 
any specialty, who may become the subjects of medical 
litigation, including dermatologists18. Furthermore, infor-
med consent should be obtained from the patients in all 
treatment courses. Table 3 summarizes the alleged viola-
tion of duty and the admitted fault (type of negligence/ 
malpractice) by the court for each case in the present 
study.
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In the first step, medical staff is likely to perform a medical 
error most commonly. Lydiatt16 reported that more than 
half of the 99 skin cancer-related lawsuits (54%) occurred 
due to the diagnostic error for the skin cancer, and about 
half of them (48%) were not confirmed by biopsy. Jackson18 
reported that in 75 melanoma-related malpractice cases, 
the medical error of delay in making diagnosis was mostly 
common (29%). Case #1 of this study involved the de-
layed biopsy caused by misdiagnosis; whereas, case #4 
was related to the misdiagnosis of the skin cancer, which 
led to the medical litigation. It is necessary to perform a 
prompt skin biopsy if there are suspected findings.
The second step involves a diagnostic error even after an 
initial diagnosis. There may be late checking of the patho-
logic result following a histopathologic diagnosis. The cas-
es #2 and #3 showed pitfalls in checking the pathologic 
reports. In case #3, the histopathologic findings of the skin 
cancer were found in the third biopsy specimen, but the 
medical staff did not confirm the results. One study in 
Korea reported that in 3% of the cases, the patients did 
not visit the hospital after the biopsy for checking the re-
sult, many of which included findings of malignancy19. As 
a plan of prevention, it is necessary to make an automated 
notification system and deliver the abnormal findings such 
as malignant tumors to the medical staff or patients19,20. 
Physicians should consider the possibility of interpretation 
error while specimen processing16,18. Crowson21 found 25 
significant errors in a retrospective study of the pathologic 
results of 35,765 cases. In this study, a medical pitfall of 
the pathology department was noted in case #5, resulting 
in the judgement in favor of the plaintiff. The errors in the 
histopathological diagnosis of the MM mentioned in the 
court rulings sentence were considered in the method of 
staining and interpretation. To prevent a pathologist’s er-
ror of interpretation, it is necessary to make the diagnosis 
in cooperation with a clinician or by obtaining a second 
opinion from another pathologist in cases with unclear 
pathologic results22. 
There can also be medical disputes in the third step; the 
so-called performance error. In skin cancer patients, re-
currence should always be searched for by regular fol-
low-ups. The clinicians should keep newly updated guide-
lines in mind and consider additional diagnostic plan for 
metastasis23. In case #6, the main disputed pitfall was the 
failure in performing the regular follow-up observation. 
It is important to obtain an informed consent from the pa-
tients at all steps of the medical practice. The current 
Medical Service Act (Article 24-2, https://elaw.klri.re.kr/kor_ 
service/lawView.do?hseq=40970&lang=ENG) specifically 
stipulates the obligation of the medical staff to explain the 
patients the possible risks involved in cases of invasive 
procedures. However, in addition to the means of avoid-
ing legal liability by the medical practitioners themselves, 
an informed consent is also necessary to ensure the pa-
tient’s right to self-determination24. The judicial precedents 
showed that misdiagnosis does not always mean 
malpractice. The court decision in the precedent case #4 
was that there was no fault of the medical staff. The reason 
for the court rulings was that, the dentist had no obligation 
to perform the diagnostic studies for the nevus without the 
suspected symptoms of the MM during the implant 
procedure. In the precedent case #7 also, the negligence 
for delayed diagnosis in the patient with ambiguous phys-
ical or laboratory findings involving cutaneous lymphoma 
was not admitted. Peripheral T cell lymphoma was diag-
nosed based on the World Health Organization classi-
fication system along with clinical and laboratory 
information. Some cases are difficult to diagnose cor-
rectly25. In this regard, the judge sentenced that the patient 
being younger and without nodal involvement or any typi-
cal laboratory result, it was difficult to diagnose peripheral 
T cell lymphoma. If the medical disputes occur despite the 
best care, the physician should give prima facie evidence 
of the reason to the judge, and it will help the judge to 
make the correct decision.
In the cases with the judgments in favor of the plaintiffs, 
the court limited the defendants’ liability for several rea-
sons that affected the deterioration progress and diagnosis 
of the skin cancer. First reason involved the characteristics 
of the disease itself as a major cause of liability limitation. 
Especially in the cases involving the MM, the court noted 
the characteristics of poor malignancy and diagnostic diffi-
culties of the MM itself. Moreover, since the 5-year surviv-
al rate was low in the state of advanced cancer, the limi-
tation of liability by the court rulings included the diffi-
culty to estimate the duration of treatment or avoid ex-
tensive resection of cancerous lesions, even though the 
prompt diagnosis and treatment were noted. Second, the 
factor of patient was also the reason for the limitation of li-
ability, involving the deterioration of disease course. Not 
attending the follow-up for further medical examination 
for a certain period despite the change of symptoms is a 
factor of liability limitation related to the patients. 
This study had some limitations. First, information on 
medical records could not be verified because, this study 
was based on the limited clinical information provided in 
the official copies of the written judgments. In addition, 7 
litigated cases are not sufficient in representing all the 
medical disputes related to the skin cancer. This suggests 
that it is necessary to research on the disputes other than 
the lawsuits, such as registered with the Korea Medical 
Dispute Meditation and Arbitration Agency. Furthermore, 
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a future analysis of the new judicial precedents of skin 
cancer will be needed. However, this study is meaningful 
in that it is the first paper to systematically analyze the 
medical disputes related to the skin cancer in Korea by 
identifying and analyzing all the litigation cases related to 
the skin cancer in Korea.
In conclusion, the incidence of skin cancer is increasing, 
and it is expected to lead to more medical malpractice 
claims in future. Analysis of judicial decision can be help-
ful to prevent medical malpractices and reduce legal risk 
for physicians. In order to prevent medical malpractices, a 
physician should make prompt diagnosis or treatment 
plans based on appropriate interpretation of the clinical or 
laboratory results. In all courses of medical practice, in-
formed consent should be obtained with detailed ex-
planation to the patients. 
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